Impact of Oral Zinc Supplementation on Serum Bilirubin Levels in Neonates with Hyperbilirubinemia Undergoing Phototherapy: An Open-Label Randomized Controlled Trial
Phase 2
- Conditions
- Health Condition 1: P84- Other problems with newborn
- Registration Number
- CTRI/2024/08/071828
- Lead Sponsor
- Dr Supreeth sv
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All late preterm(=35weeks), term, post term neonates admitted with hyperbilirubinemia in phototherapy range.
Exclusion Criteria
Neonates with direct hyperbilirubinemia
• Major gross congenital anomalies (gastrointerstinal malformations, heart defects, neural tube defects) and with identifiable genetic syndromes.
• Preterm neonate(=35weeks), who are already started on zinc supplementation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method